FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101810266> ?p ?o ?g. }

• W2101810266 endingPage "67" @default.
• W2101810266 startingPage "61" @default.
• W2101810266 abstract "BackgroundIn contrast to volatile anaesthetics, xenon acts by antagonism at N-methyl-d-aspartate receptors and antagonizes 5-hydroxytryptamine type 3 receptors that mediate nausea and vomiting. Therefore, it is unknown whether the same risk factors for postoperative nausea and vomiting (PONV) after volatile anaesthetics apply to xenon-based anaesthesia.MethodsWith ethics committee approval and written informed consent, 502 consecutive patients undergoing xenon-based anaesthesia were included in a multicentre prospective observational study. Antiemetic prophylaxis was administered at the discretion of the attending anaesthetists. Postoperative nausea and vomiting and need for antiemetic rescue medication were assessed for 24 h after anaesthesia. Multivariate logistic regression analysis was performed to quantify risk factors for PONV and need for rescue medication.ResultsFour hundred and eighty-eight subjects were available for the final analysis. The incidence of PONV in subjects without prophylaxis was lower than expected according to the Apfel Score (28% observed; 42% expected, P<0.001). Independent predictors for PONV were (adjusted odds ratio; 95% confidence interval) female sex (1.76; 1.08–2.89), younger patient age (0.82 per 10 yr; 0.69–0.97), and longer duration of anaesthesia (1.36 per hour; 1.17–1.59).ConclusionsThe incidence of PONV was significantly lower than predicted by the Apfel Score. Female sex, younger age, and longer duration of anaesthesia are risk factors for PONV after xenon-based anaesthesia.Clinical trial registrationGerman Federal Institute for Drugs and Medical Devices number AL-PMS-01/07GER. In contrast to volatile anaesthetics, xenon acts by antagonism at N-methyl-d-aspartate receptors and antagonizes 5-hydroxytryptamine type 3 receptors that mediate nausea and vomiting. Therefore, it is unknown whether the same risk factors for postoperative nausea and vomiting (PONV) after volatile anaesthetics apply to xenon-based anaesthesia. With ethics committee approval and written informed consent, 502 consecutive patients undergoing xenon-based anaesthesia were included in a multicentre prospective observational study. Antiemetic prophylaxis was administered at the discretion of the attending anaesthetists. Postoperative nausea and vomiting and need for antiemetic rescue medication were assessed for 24 h after anaesthesia. Multivariate logistic regression analysis was performed to quantify risk factors for PONV and need for rescue medication. Four hundred and eighty-eight subjects were available for the final analysis. The incidence of PONV in subjects without prophylaxis was lower than expected according to the Apfel Score (28% observed; 42% expected, P<0.001). Independent predictors for PONV were (adjusted odds ratio; 95% confidence interval) female sex (1.76; 1.08–2.89), younger patient age (0.82 per 10 yr; 0.69–0.97), and longer duration of anaesthesia (1.36 per hour; 1.17–1.59). The incidence of PONV was significantly lower than predicted by the Apfel Score. Female sex, younger age, and longer duration of anaesthesia are risk factors for PONV after xenon-based anaesthesia." @default.
• W2101810266 created "2016-06-24" @default.
• W2101810266 creator A5000845703 @default.
• W2101810266 creator A5002596114 @default.
• W2101810266 creator A5017553592 @default.
• W2101810266 creator A5021653813 @default.
• W2101810266 creator A5021948082 @default.
• W2101810266 creator A5022084444 @default.
• W2101810266 creator A5033984768 @default.
• W2101810266 creator A5036649021 @default.
• W2101810266 creator A5044819841 @default.
• W2101810266 creator A5088103292 @default.
• W2101810266 date "2015-07-01" @default.
• W2101810266 modified "2023-10-01" @default.
• W2101810266 title "Predictors for postoperative nausea and vomiting after xenon-based anaesthesia" @default.
• W2101810266 cites W1384845 @default.
• W2101810266 cites W1970717048 @default.
• W2101810266 cites W1988122638 @default.
• W2101810266 cites W2006929183 @default.
• W2101810266 cites W2010482008 @default.
• W2101810266 cites W2027206415 @default.
• W2101810266 cites W2033796406 @default.
• W2101810266 cites W2036193982 @default.
• W2101810266 cites W2037668591 @default.
• W2101810266 cites W2039621084 @default.
• W2101810266 cites W2061066346 @default.
• W2101810266 cites W2071197542 @default.
• W2101810266 cites W2087484885 @default.
• W2101810266 cites W2087739990 @default.
• W2101810266 cites W2098364806 @default.
• W2101810266 cites W2105384005 @default.
• W2101810266 cites W2107246366 @default.
• W2101810266 cites W2107382304 @default.
• W2101810266 cites W2111635289 @default.
• W2101810266 cites W2112692238 @default.
• W2101810266 cites W2123683153 @default.
• W2101810266 cites W2129586953 @default.
• W2101810266 cites W2130373985 @default.
• W2101810266 cites W2131475566 @default.
• W2101810266 cites W2135439310 @default.
• W2101810266 cites W2142885377 @default.
• W2101810266 cites W2153045759 @default.
• W2101810266 cites W2153801682 @default.
• W2101810266 cites W2154735290 @default.
• W2101810266 cites W2157134275 @default.
• W2101810266 cites W2157151498 @default.
• W2101810266 cites W2160759330 @default.
• W2101810266 cites W2161896406 @default.
• W2101810266 cites W2164551944 @default.
• W2101810266 cites W2165137445 @default.
• W2101810266 cites W4242672631 @default.
• W2101810266 cites W4243677959 @default.
• W2101810266 cites W4250430731 @default.
• W2101810266 doi "https://doi.org/10.1093/bja/aev115" @default.
• W2101810266 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25962612" @default.
• W2101810266 hasPublicationYear "2015" @default.
• W2101810266 type Work @default.
• W2101810266 sameAs 2101810266 @default.
• W2101810266 citedByCount "14" @default.
• W2101810266 countsByYear W21018102662016 @default.
• W2101810266 countsByYear W21018102662017 @default.
• W2101810266 countsByYear W21018102662018 @default.
• W2101810266 countsByYear W21018102662019 @default.
• W2101810266 countsByYear W21018102662020 @default.
• W2101810266 crossrefType "journal-article" @default.
• W2101810266 hasAuthorship W2101810266A5000845703 @default.
• W2101810266 hasAuthorship W2101810266A5002596114 @default.
• W2101810266 hasAuthorship W2101810266A5017553592 @default.
• W2101810266 hasAuthorship W2101810266A5021653813 @default.
• W2101810266 hasAuthorship W2101810266A5021948082 @default.
• W2101810266 hasAuthorship W2101810266A5022084444 @default.
• W2101810266 hasAuthorship W2101810266A5033984768 @default.
• W2101810266 hasAuthorship W2101810266A5036649021 @default.
• W2101810266 hasAuthorship W2101810266A5044819841 @default.
• W2101810266 hasAuthorship W2101810266A5088103292 @default.
• W2101810266 hasBestOaLocation W21018102661 @default.
• W2101810266 hasConcept C126322002 @default.
• W2101810266 hasConcept C156957248 @default.
• W2101810266 hasConcept C2776983577 @default.
• W2101810266 hasConcept C2777297131 @default.
• W2101810266 hasConcept C2780580376 @default.
• W2101810266 hasConcept C2780852908 @default.
• W2101810266 hasConcept C2780884295 @default.
• W2101810266 hasConcept C42219234 @default.
• W2101810266 hasConcept C44249647 @default.
• W2101810266 hasConcept C71924100 @default.
• W2101810266 hasConceptScore W2101810266C126322002 @default.
• W2101810266 hasConceptScore W2101810266C156957248 @default.
• W2101810266 hasConceptScore W2101810266C2776983577 @default.
• W2101810266 hasConceptScore W2101810266C2777297131 @default.
• W2101810266 hasConceptScore W2101810266C2780580376 @default.
• W2101810266 hasConceptScore W2101810266C2780852908 @default.
• W2101810266 hasConceptScore W2101810266C2780884295 @default.
• W2101810266 hasConceptScore W2101810266C42219234 @default.
• W2101810266 hasConceptScore W2101810266C44249647 @default.
• W2101810266 hasConceptScore W2101810266C71924100 @default.
• W2101810266 hasIssue "1" @default.
• W2101810266 hasLocation W21018102661 @default.

• next